Back to Screener

Spectral AI, Inc. Warrants (MDAIW)

Price$0.68

Favorite Metrics

Price vs S&P 500 (26W)-11.33%
Price vs S&P 500 (4W)25.39%

All Metrics

Price vs S&P 500 (YTD)51.73%
10-Day Avg Trading Volume0.01M
3-Month Avg Trading Volume0.01M
52-Week Price Return135.13%
52-Week High$1.01
26-Week Price Return-2.58%
13-Week Price Return55.90%
3-Month Return Std Dev85.74%
Price vs S&P 500 (52W)100.04%
Year-to-Date Return55.87%
5-Day Price Return16.92%
Month-to-Date Return25.27%
Price vs S&P 500 (13W)53.04%
Beta4.57x
52-Week Low$0.22

Industry Peers — Surgical & Medical Instruments(109)

SymbolP/S Ratio (TTM)Revenue Growth (5Y)Gross Margin (TTM)Operating Margin (TTM)Price
MDAIWSpectral AI, Inc. Warrants
$0.68
SYKStryker Corporation
5.17x11.84%64.57%19.43%$338.34
BSXBoston Scientific Corp.
4.58x15.16%69.01%18.00%$60.99
MMM3M Company
3.21x-4.97%39.92%18.55%$151.40
MDLNMedline Inc. Class A common stock
2.20x26.44%7.78%$48.26
BDXBecton, Dickinson and Co.
2.06x6.32%46.42%12.15%$158.64
RMDResMed Inc.
6.07x11.72%60.85%33.70%$226.14
DXCMDexCom, Inc.
5.33x19.33%62.09%19.56%$64.62
WSTWest Pharmaceutical Services, Inc.
6.29x7.44%35.91%19.03%$278.00
PODDInsulet Corporation
5.19x24.53%71.63%12.92%$200.87
PENPenumbra, Inc.
9.24x20.16%67.14%13.48%$329.71

About

Spectral AI develops AI-powered medical diagnostic imaging for wound care. Its DeepView System, which holds FDA Breakthrough Device designation, uses proprietary algorithms to distinguish between damaged and healthy tissue and deliver healing assessments in seconds. The platform enables physicians to make faster, more accurate treatment decisions and improve clinical outcomes.